Universal Ibogaine Inc (IBO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2024 | 10-2023 | 07-2023 | 04-2023 | 01-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 82 | 84 | 88 | 72 | 69 |
| Accounts receivable | N/A | -170 | N/A | N/A | N/A |
| Other Working Capital | 55 | -74 | 62 | 199 | 8 |
| Other Operating Activity | -205 | -24 | -144 | -444 | -558 |
| Operating Cash Flow | $-68 | $-184 | $6 | $-172 | $-481 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -30 | 37 | -43 | -211 |
| Investing Cash Flow | $-9 | $-30 | $37 | $-43 | $-211 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | -54 | 380 | 197 |
| Debt Repayment | -32 | -38 | -29 | -4 | -17 |
| Common Stock Issued | 317 | 100 | 0 | 0 | 0 |
| Other Financing Activity | -3 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $282 | $62 | $-82 | $376 | $180 |
| Beginning Cash Position | 160 | 313 | 353 | 192 | 704 |
| End Cash Position | 365 | 160 | 313 | 353 | 192 |
| Net Cash Flow | $204 | $-153 | $-40 | $161 | $-512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68 | -184 | 6 | -172 | -481 |
| Capital Expenditure | -9 | -30 | N/A | -43 | -211 |
| Free Cash Flow | -77 | -215 | 6 | -215 | -691 |